摩通发表报告指，创科(00669.HK) 2024财年业绩表现强劲，亮点包括Milwaukee强劲的销售增长、毛利率扩张、创纪录的自由现金流、派息增加。在公司在3月4日收市后公布财报后，该行更新了对其财务模型。将目标价由今年12月135元，上调至明年12月138元，并维持“增持”评级。
报告指，创科去年下半年稳健的利润被较高的利息成本轻微抵消。随着公司加速去杠杆化，至2024年底净负债率降至0.7%，成为2025年的积极因素。管理层业绩电话会议关注点包括2025年增长指引、关税影响应对、持续创新与效率。(ha/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-06 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.